STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

HSIC HENRY SCHEIN INCORPORATED StockScouter® Report

8

StockScouter® Score

HENRY SCHEIN INCORPORATED, a mid cap value company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral
  • Moving average analysis for HSIC suggests upward price movement over the medium term. Positive

 

Concerns

  • One or more analysts has modestly decreased quarterly earnings estimates for HSIC. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, value stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

C
C
A
B

Previous Ratings

9
7
7